Infection Is Not a Risk Factor for Perioperative and Postoperative Blood Loss and Transfusion in Revision Total Hip Arthroplasty

Journal of Arthroplasty

Volumn 32, Issue 1, 2017, Pages 214-219.e1

  George, Jaiben ^a   Sikora, Matthew ^a   Masch, Jessica ^a   Farias Kovac, Mario ^a   Klika, Alison K ^a   Higuera, Carlos A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

blood loss; hip arthroplasty; infection; revision; transfusion

Indexed keywords

HEMOGLOBIN;

ADULT; AGE; ARTICLE; BLOOD TRANSFUSION; BODY MASS; CHARLSON COMORBIDITY INDEX; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HIP ARTHROPLASTY; HUMAN; INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OPERATIVE BLOOD LOSS; OUTCOME ASSESSMENT; PERIPROSTHETIC JOINT INFECTION; POSTOPERATIVE HEMORRHAGE; PREDICTIVE VALUE; PROGNOSIS; REOPERATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TOTAL HIP PROSTHESIS; AGED; COMPLICATION; HIP REPLACEMENT; JOINT; NOMOGRAM;

AGED; ARTHROPLASTY, REPLACEMENT, HIP; BLOOD TRANSFUSION; FEMALE; HUMANS; JOINTS; MALE; MIDDLE AGED; NOMOGRAMS; POSTOPERATIVE HEMORRHAGE; PROSTHESIS-RELATED INFECTIONS; REOPERATION; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84994249016     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2016.06.046     Document Type: Article

References (24)

1. 1 Bozic, K.J., Ries, M.D., The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization. J Bone Joint Surg Am, 87, 2005, 1746.
2. 2 Mahadevan, D., Challand, C., Keenan, J., Revision total hip replacement: predictors of blood loss, transfusion requirements, and length of hospitalisation. J Orthop Traumatol, 11, 2010, 159.
3. 3 Romanò, C.L., Romanò, D., Logoluso, N., et al. Septic versus aseptic hip revision: how different?. J Orthop Traumatol, 11, 2010, 167.
4. 4 Esper, S.A., Waters, J.H., Intra-operative cell salvage: a fresh look at the indications and contraindications. Blood Transfus, 9, 2011, 139.
5. 5 Blumberg, N., Heal, J.M., Immunomodulation by blood transfusion: an evolving scientific and clinical challenge. Am J Med, 101, 1996, 299.
6. 6 Hill, G.E., Frawley, W.H., Griffith, K.E., et al. Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. J Trauma, 54, 2003, 908.
7. 7 Mortazavi, S.M.J., Schwartzenberger, J., Austin, M.S., et al. Revision total knee arthroplasty infection: incidence and predictors. Clin Orthop Relat Res, 468, 2010, 2052.
8. 8 Steinitz, D., Harvey, E.J., Leighton, R.K., et al. Is homologous blood transfusion a risk factor for infection after hip replacement?. Can J Surg, 44, 2001, 355.
9. 9 Saleh, A., Small, T., Chandran Pillai, A.L., et al. Allogenic blood transfusion following total hip arthroplasty: results from the nationwide inpatient sample, 2000 to 2009. J Bone Joint Surg Am, 96, 2014, e155.
10. 10 Parvizi, J., Ghanem, E., Joshi, A., et al. Does “excessive” anticoagulation predispose to periprosthetic infection?. J Arthroplasty, 22, 2007, 24.
11. 11 Parvizi, J., Gehrke, T., Definition of periprosthetic joint infection. J Arthroplasty, 29, 2014, 1331.
12. 12 Rosencher, N., Kerkkamp, H.E., Macheras, G., et al. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion, 43, 2003, 459.
13. 13 Brecher, M.E., Monk, T., Goodnough, L.T., A standardized method for calculating blood loss. Transfusion, 37, 1997, 1070.
14. 14 Schorn, M.N., Measurement of blood loss: review of the literature. J Midwifery Womens Health, 55, 2010, 20.
15. 15 Frisch, N.B., Wessell, N.M., Charters, M.A., et al. Predictors and complications of blood transfusion in total hip and knee arthroplasty. J Arthroplasty, 29, 2014, 189.
16. 16 Park, J.H., Rasouli, M.R., Mortazavi, S.M., et al. Predictors of perioperative blood loss in total joint arthroplasty. J Bone Joint Surg Am, 95, 2013, 1777.
17. 17 Harrell Jr FE. rms: regression modeling strategies. R package version 4.4-0. http://CRAN.R-project.org/package=rms 2015.
18. 18 Iorio, R., Healy, W.L., Richards, J.A., Comparison of the hospital cost of primary and revision total knee arthroplasty after cost containment. Orthopedics, 22, 1999, 195.
19. 19 Callaghan, J.J., Spitzer, A.I., Blood management and patient specific transfusion options in total joint replacement surgery. Iowa Orthop J, 20, 2000, 36.
20. 20 Bell, T.H., Berta, D., Ralley, F., et al. Factors affecting perioperative blood loss and transfusion rates in primary total joint arthroplasty: a prospective analysis of 1642 patients. Can J Surg, 52, 2009, 295.
21. 21 MacKinnon, D.P., Fairchild, A.J., Fritz, M.S., Mediation analysis. Annu Rev Psychol, 58, 2007, 593.
22. 22 Sculco, T.P., The economic impact of infected total joint arthroplasty. Instr Course Lect, 42, 1993, 349.
23. 23 Hatzidakis, A.M., Mendlick, R.M., McKillip, T., et al. Preoperative autologous donation for total joint arthroplasty. An analysis of risk factors for allogenic transfusion. J Bone Joint Surg Am, 82, 2000, 89.
24. 24 Blumberg, N., Kirkley, S.A., Heal, J.M., A cost analysis of autologous and allogeneic transfusions in hip-replacement surgery. Am J Surg, 171, 1996, 324.